Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis

Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening autoinflammatory skin disease, mainly mediated by the interleukin (IL)-36 signaling pathway. The irregular and relapsing pattern of the skin symptoms, the GPP-associated complications, as well as the physical pain caused...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Shuai, Wang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674804/
https://www.ncbi.nlm.nih.gov/pubmed/36208408
http://dx.doi.org/10.1007/s13555-022-00830-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674804/
https://www.ncbi.nlm.nih.gov/pubmed/36208408
http://dx.doi.org/10.1007/s13555-022-00830-x

Ejemplares similares